Carnitine status and safety after administration of S-1108, a new oral cephem, to patients.

Benzer Materyaller

• Metabolism of S-1108, a new oral cephem antibiotic, and metabolic profiles of its metabolites in humans.
  Yazar:: Totsuka, K, ve diğerleri
  Baskı/Yayın Bilgisi: (1992)
• Disposition of S-1108, a new oral cephem antibiotic, and metabolic fate of pivalic acid liberated from [pivaloyl-14C]S-1108 in rats and dogs.
  Yazar:: Mizojiri, K, ve diğerleri
  Baskı/Yayın Bilgisi: (1995)
• Phase I clinical studies of S-1108: safety and pharmacokinetics in a multiple-administration study with special emphasis on the influence on carnitine body stores.
  Yazar:: Nakashima, M, ve diğerleri
  Baskı/Yayın Bilgisi: (1992)
• Phase I Clinical Studies of S-1108: Safety and Pharmacokinetics in a Multiple-Administration Study with Special Emphasis on the Influence on Carnitine Body Stores
  Yazar:: Nakashima, M., ve diğerleri
  Baskı/Yayın Bilgisi: (1992)
• Disposition of S-1108, a New Oral Cephem Antibiotic, and Metabolic Fate of Pivalic Acid Liberated from [pivaloyl-(14)C]S-1108 in Rats and Dogs
  Yazar:: Mizojiri, Kenji, ve diğerleri
  Baskı/Yayın Bilgisi: (1995)